BLRAX
Price
$11.09
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Net Assets
152.63M
CSSPX
Price
$51.30
Change
+$0.07 (+0.14%)
Updated
Jan 17 closing price
Net Assets
1.75B
Ad is loading...

BLRAX vs CSSPX

Header iconBLRAX vs CSSPX Comparison
Open Charts BLRAX vs CSSPXBanner chart's image
Brookfield Global Listed Real Estate A
Price$11.09
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets152.63M
Cohen & Steers Global Realty I
Price$51.30
Change+$0.07 (+0.14%)
VolumeN/A
Net Assets1.75B
BLRAX vs CSSPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BLRAX vs. CSSPX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLRAX is a Hold and CSSPX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
CSSPX has more cash in the bank: 1.75B vs. BLRAX (153M). CSSPX pays higher dividends than BLRAX: CSSPX (2.86) vs BLRAX (2.49). BLRAX was incepted earlier than CSSPX: BLRAX (13 years) vs CSSPX (28 years). BLRAX is a more actively managed with annual turnover of: 91.00 vs. CSSPX (52.00). BLRAX has a lower initial minimum investment than CSSPX: BLRAX (1000) vs CSSPX (100000). BLRAX (6.24) and CSSPX (5.98) have marching annual gain over last year. CSSPX return over 5 years is better than : 2.07 vs. BLRAX (-8.82).
BLRAXCSSPXBLRAX / CSSPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years28 years-
Gain YTD-0.0900.509-18%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets153M1.75B9%
Annual Yield % from dividends2.492.8687%
Returns for 1 year6.245.98104%
Returns for 3 years-14.74-12.49118%
Returns for 5 years-8.822.07-425%
Returns for 10 years8.8834.2926%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INTA67.481.10
+1.66%
Intapp
VINP9.760.08
+0.83%
Vinci Partners Investments Ltd
SRPT118.000.94
+0.80%
Sarepta Therapeutics
ATNF1.56-0.02
-1.27%
180 Life Sciences Corp
CXAI1.79-0.10
-5.29%
CXApp